Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000320017-24-000058
Filing Date
2024-11-12
Accepted
2024-11-12 16:10:45
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lsta-20240930.htm   iXBRL 10-Q 955960
2 EX-31.1 lsta-ex311_20240930.htm EX-31.1 9601
3 EX-31.2 lsta-ex312_20240930.htm EX-31.2 9643
4 EX-32.1 lsta-ex321_20240930.htm EX-32.1 6856
5 EX-32.2 lsta-ex322_20240930.htm EX-32.2 6933
11 lsta-20240930_g1.jpg GRAPHIC 188118
  Complete submission text file 0000320017-24-000058.txt   6629617

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lsta-20240930.xsd EX-101.SCH 46322
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lsta-20240930_cal.xml EX-101.CAL 58976
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lsta-20240930_def.xml EX-101.DEF 179844
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lsta-20240930_lab.xml EX-101.LAB 639187
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lsta-20240930_pre.xml EX-101.PRE 429349
83 EXTRACTED XBRL INSTANCE DOCUMENT lsta-20240930_htm.xml XML 772981
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33650 | Film No.: 241448204
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)